Enanta Pharmaceuticals Inc at JMP Securities Life Sciences Conference Transcript
Thank you for joining us again, here for the JMP Securities Life Science Conference. My name is Roy Buchanan. I'm one of the biotech equity analysts, and we're happy to have with us Enanta Pharmaceuticals. We have Jay Luly, President and CEO; and Tara Kieffer, she is Senior Vice President of New Product Strategy and Development with us here today.
So Jay and Tara, thank you for joining us, really excited to have you here. Very exciting time at Enanta. You just had the Phase 2 readout for, what I view as your lead candidate EDP-235 for treating coronavirus. Pretty broad pipeline otherwise, couple of candidates in RSV, et cetera. Maybe just give us thirty seconds on what Enanta does, and where you guys came from?
Sure. That's a --
30 seconds --
30
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
